E Fund Management’s Vaxart VXRT Stock Holding History

E Fund Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-72,516	Closed	-$158K	–	355
2022 Q3	$158K	Buy	72,516 +10,902	+18%	+$37.6K	0.01%	315
2022 Q2	$216K	Buy	61,614 +11,625	+23%	+$43.4K	0.02%	291
2022 Q1	$252K	Buy	49,989 +22,246	+80%	+$113K	0.01%	256
2021 Q4	$174K	Buy	27,743 +7,940	+40%	+$54.2K	0.01%	273
2021 Q3	$157K	Buy	+19,803	New	+$163K	0.01%	245
2021 Q1	$124K	Buy	+20,573	New	+$158K	0.01%	232

Other funds holding VXRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

E Fund Management's VXRT Position: Q4 2022 in Review

E Fund Management sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 72,516 shares — an estimated $158K sold.

E Fund Management first reported a position in VXRT in Q1 2021 and held it in 6 quarters. The position peaked at $252K in Q1 2022. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

E Fund Management reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
E Fund Management sold 72,516 Vaxart shares in Q4 2022, an estimated $158K.
E Fund Management first reported a position in Vaxart in Q1 2021 and held it in 6 quarters.
E Fund Management's Vaxart position peaked at $252K in Q1 2022.
132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on E Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.